talazoparib,enzalutamide
pfizer,astellas
[]
 great to see these groundbreaking trials reaching their end points!
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.